Verified Document

Incurable Diseases Afflicting The World Research Paper

(Associated Press) This means that patients would be able to decide whether or not to undergo treatment with Provenge irrespective of cost. The subsidization of expensive medical treatments by the Medicare program is actually nothing new. Medicare already pays for other expensive cancer treatments from companies such as Genentech and Eli Lilly. (Associated Press) However, the recent backlash against government expenditures on healthcare has compelled the Medicare program to give closer scrutiny to the drugs it agrees to cover. There were many who were surprised, and offended, that the Medicare program even considered the possibility of not covering Provenge treatments. (Associated Press) These people believe that the federal government's commitment to cover the health care costs of older individuals is absolute. They believe that this responsibility does not have a price limit.

Conclusion

Prostate cancer patients seem to have received the best of all worlds with the recent developments involving Sipuleucel-T. They are the first in line to receive a highly sophisticated, groundbreaking new cancer treatment while not having to pay the costs typically associated...

However, it is uncertain whether the federal government will continue to cover the costs of such treatments. Thus, medical breakthroughs such as Sipuleucel-T may not always get through to everyone who needs them.
Bibliography

P.W. Kantoff, C.S. Higano, N.D. Shore, et al. (2010). "Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer." New England Journal of Medicine 363: 411 -- 422. Available at http://www.nejm.org/doi/pdf/10.1056/NEJMoa1001294.

"Survival Benefit of Sipuleucel-T in Prostate Cancer Appears Durable." Elsevier Global Medical News. Mar 11, 2010. Available at http://www.oncologystat.com/news/Survival_Benefit_of_Sipuleucel-T_in_Prostate_Cancer_Appears_Durable_US.html.

"Dendreon Cancer Drug Faces U.S. Review Tied to Its Sole Product." Catherine Larkin. Nov. 16, 2010. Available at http://www.bloomberg.com/news/2010-11-16/dendreon-cancer-drug-faces-u-s-review-tied-to-its-sole-product.html

"Medicare panel backs $93K cancer drug Provenge." Associated Press. Nov. 18, 2010. Available at http://www.usatoday.com/yourlife/health/medical/cancer/2010-11-18-provenge-medicare_N.htm

Sources used in this document:
Bibliography

P.W. Kantoff, C.S. Higano, N.D. Shore, et al. (2010). "Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer." New England Journal of Medicine 363: 411 -- 422. Available at http://www.nejm.org/doi/pdf/10.1056/NEJMoa1001294.

"Survival Benefit of Sipuleucel-T in Prostate Cancer Appears Durable." Elsevier Global Medical News. Mar 11, 2010. Available at http://www.oncologystat.com/news/Survival_Benefit_of_Sipuleucel-T_in_Prostate_Cancer_Appears_Durable_US.html.

"Dendreon Cancer Drug Faces U.S. Review Tied to Its Sole Product." Catherine Larkin. Nov. 16, 2010. Available at http://www.bloomberg.com/news/2010-11-16/dendreon-cancer-drug-faces-u-s-review-tied-to-its-sole-product.html

"Medicare panel backs $93K cancer drug Provenge." Associated Press. Nov. 18, 2010. Available at http://www.usatoday.com/yourlife/health/medical/cancer/2010-11-18-provenge-medicare_N.htm
Cite this Document:
Copy Bibliography Citation

Related Documents

Prostate Cancer
Words: 876 Length: 3 Document Type: Term Paper

Prostate Cancer Issues in Healthcare Prostate Cancer is a cancer of the prostate which affects men. 190,000 new cases are detected each year in America, making it the most common cancer among men. Additionally, prostate cancer has grown 192% between 1973 and 1992. (PCA) There are social, environmental and political conditions which currently exist and may affect a prostate cancer victim's access to health care or other services. Some of these issues

Prostate Cancer in America
Words: 1896 Length: 5 Document Type: Article Review

Prostate Cancer in America Prostrate Cancer Prostate cancer is the cancer of the prostate glands. Prostate gland is a small walnut sized organ and an important part of a man's reproductive system. It is one of the most common forms of cancer in men aged above 75 years. The incidence of prostate cancer in men younger than the age of 40 is very rare. High risk population for the prostate cancer include

Prostate Cancer Is a Slow
Words: 1374 Length: 4 Document Type: Essay

All patients who suffered from inhalation injuries must be given a compulsory bronchoscopic examination so as to reveal the extent of respiratory injury and also to help in planning of the most suitable treatment. References McCance, K.A. & Huether, S.E. (2010). Pathophysiology: The biologic basis for disease in adults and children (6th ed). St. Louis: Mosby. Module 8 (B) Hypovolemic shock Hypovolemic shock is noted by McCance and Huether (2010) to be an emergency condition

Prostate Cancer Older Men's Dread
Words: 2018 Length: 8 Document Type: Term Paper

The husband's physical recovery did not indicate the life changes they must contend with. These changes included grief over the loss of intimacy between them, the changes in the nature of their relationship, misguided individual expectations, a lack of interpersonal communication and the lack of professional information to help and enlighten them. The process of trying to recover sexual function led them to seek out many treatment modes. Most

Prostate Cancer Describe the Pathophysiology
Words: 1146 Length: 3 Document Type: Essay

There are three main treatment options. For tumors that are still inside the prostate, a surgery called radical prostatectomy and radiation therapy are common treatment options (Prostate cancer treatment options). This source describes these two options. Radical prostatectomy removes the whole prostate gland and the nearby lymph nodes. There are 2 types of radiation therapy, external beam radiation therapy and seed therapy also called brachytherapy. In external beam radiation therapy,

Prostate Cancer Plan
Words: 2412 Length: 8 Document Type: Research Proposal

Prostate cancer is a type of cancer that develops in the male reproductive system, and most prostate cancer can be slow growing. However, there are still aggressive type of prostate cancers, because the cancer cells can spread from the prostate of a patient to all other part of the body particularly the lymph nodes and bones. Initially, prostate cancer may reveal no symptom, however, in a later stage, it can

Sign Up for Unlimited Study Help

Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.

Get Started Now